Canada Pension Plan Investment Board Bei Gene, Ltd. Transaction History

Canada Pension Plan Investment Board

$97.2 Billion
Q4 2024

A detailed history of Canada Pension Plan Investment Board transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 50,000 shares of BGNE stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,000

Holding current value

$11.3 Million

% of portfolio

0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$174.72 - $246.04 $8.74 Million - $12.3 Million	50,000 New	50,000 $9.24 Million
Q1 2024 May 14, 2024	BUY	$141.8 - $181.47 $2.41 Million - $3.08 Million	17,000 New	17,000 $2.66 Million
Q2 2023 Aug 09, 2023	BUY	$178.3 - $266.78 $9.41 Million - $14.1 Million	52,800 New	52,800 $9.41 Million
Q4 2022 Feb 14, 2023	SELL	$125.51 - $229.3 $2.64 Million - $4.82 Million	-21,039 Reduced 99.53%	100 $21,000
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $10.6 Million - $16.3 Million	-80,726 Reduced 79.25%	21,139 $2.85 Million
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $7.71 Million - $13.8 Million	63,665 Added 166.66%	101,865 $16.5 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $5.6 Million - $10.3 Million	38,200 New	38,200 $7.21 Million
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $9.05 Million - $14.2 Million	-36,408 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $13.6 Million - $17.1 Million	-46,600 Reduced 56.14%	36,408 $12.5 Million
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $16.5 Million - $24.2 Million	-63,317 Reduced 43.27%	83,008 $28.9 Million
Q4 2020 Feb 17, 2021	BUY	$221.31 - $316.61 $29.1 Million - $41.6 Million	131,525 Added 888.68%	146,325 $37.8 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $604,051 - $914,602	-3,193 Reduced 17.75%	14,800 $4.24 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $1.42 Million - $2.24 Million	11,459 Added 175.37%	17,993 $3.39 Million
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $5.41 Million - $7.69 Million	-44,380 Reduced 87.17%	6,534 $804,000
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $62.8 Million - $113 Million	-541,984 Reduced 91.41%	50,914 $8.44 Million
Q2 2019 Aug 12, 2019	SELL	$113.99 - $146.86 $64.5 Million - $83.1 Million	-565,607 Reduced 48.82%	592,898 $73.5 Million
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $4.55 Million - $5.62 Million	37,008 Added 3.3%	1,158,505 $153 Million
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $602,145 - $985,569	5,627 Added 0.5%	1,121,497 $157 Million
Q3 2018 Nov 09, 2018	BUY	$152.62 - $189.66 $18.4 Million - $22.9 Million	120,870 Added 12.15%	1,115,870 $192 Million
Q1 2018 May 14, 2018	BUY	$97.41 - $177.22 $38.5 Million - $70 Million	395,000 Added 65.83%	995,000 $167 Million
Q3 2017 Oct 30, 2017	BUY	$66.19 - $103.46 $39.7 Million - $62.1 Million	600,000	600,000 $62.1 Million

Others Institutions Holding BGNE

# of Institutions

254

Shares Held

42.4M

Call Options Held

135K

Put Options Held

111K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Account

Canada Pension Plan Investment Board Bei Gene, Ltd. Transaction History